BR0314118A - Composição antimicrobiana e método para uso - Google Patents

Composição antimicrobiana e método para uso

Info

Publication number
BR0314118A
BR0314118A BR0314118-7A BR0314118A BR0314118A BR 0314118 A BR0314118 A BR 0314118A BR 0314118 A BR0314118 A BR 0314118A BR 0314118 A BR0314118 A BR 0314118A
Authority
BR
Brazil
Prior art keywords
antimicrobial composition
composition
feed
lysozyme
intestines
Prior art date
Application number
BR0314118-7A
Other languages
English (en)
Other versions
BRPI0314118B1 (pt
Inventor
Stephen R Smith
Stewart J Ritchie
Guopeng Zhang
Original Assignee
674738 B C Ltd Dba Inovatech B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 674738 B C Ltd Dba Inovatech B filed Critical 674738 B C Ltd Dba Inovatech B
Publication of BR0314118A publication Critical patent/BR0314118A/pt
Publication of BRPI0314118B1 publication Critical patent/BRPI0314118B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"COMPOSIçãO ANTIMICROBIANA E MéTODO PARA USO". A presente invenção refere-se a uma composição antimicrobiana e a um método para administração da composição antimicrobiana através da água de beber ou ração à animais de criação, em que a composição antimicrobiana é composta de lisozima e vários outros agentes que atuam sinergisticamente com a lisozima, tais como pó de ovo seco, albume, um agente de captura e/ou um lantibiótico. A composição é usada para inibir o desenvolvimento de e doenças e efeitos epidemiológicos significativos causados por Clostridium perfringens, E. coli e Salmonella, no intestino dos animais de criação. Mais particularmente, a composição antimicrobiana e o método se referem a um aditivo para ração que pode ser administrado a aves e/ou suínos através de sua ração. O uso de tal aditivo para ração também pode inibir outros agentes patogênicos entéricos que podem estar presentes no intestino dos animais de criação.
BRPI0314118A 2002-09-18 2003-09-18 composição antimicrobiana como agente para a supressão do desenvolvimento de agentes patogênicos entéricos no intestino de animais de criação e/ou para a prevenção e tratamento de infecções gastrointestinais em animais de criação BRPI0314118B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002404356A CA2404356A1 (en) 2002-09-18 2002-09-18 Gram-positive antibacterial composition and method for use
PCT/CA2003/001359 WO2004026334A1 (en) 2002-09-18 2003-09-18 Antimicrobial composition and method for use

Publications (2)

Publication Number Publication Date
BR0314118A true BR0314118A (pt) 2005-07-12
BRPI0314118B1 BRPI0314118B1 (pt) 2016-05-10

Family

ID=32000084

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314118A BRPI0314118B1 (pt) 2002-09-18 2003-09-18 composição antimicrobiana como agente para a supressão do desenvolvimento de agentes patogênicos entéricos no intestino de animais de criação e/ou para a prevenção e tratamento de infecções gastrointestinais em animais de criação

Country Status (10)

Country Link
US (2) US20050266050A1 (pt)
EP (2) EP1539224B1 (pt)
JP (1) JP4664678B2 (pt)
AU (1) AU2003266058A1 (pt)
BR (1) BRPI0314118B1 (pt)
CA (2) CA2404356A1 (pt)
DE (1) DE60317799T2 (pt)
DK (1) DK1539224T3 (pt)
ES (1) ES2298614T3 (pt)
WO (1) WO2004026334A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI276682B (en) * 2001-11-16 2007-03-21 Mitsubishi Chem Corp Substrate surface cleaning liquid mediums and cleaning method
US20070258996A1 (en) * 2005-12-23 2007-11-08 The Sterilex Corporation Antimicrobial compositions
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
NZ582529A (en) 2007-07-20 2012-01-12 Univ Minnesota Lantibiotics from bifidobacterium longum and uses thereof
WO2011104339A1 (en) 2010-02-25 2011-09-01 Novozymes A/S Variants of a lysozyme and polynucleotides encoding same
WO2012035103A1 (en) 2010-09-16 2012-03-22 Novozymes A/S Lysozymes
ITMI20111555A1 (it) * 2011-08-29 2013-03-01 Cevolani Daniele S R L Mangimi e composizioni per uso veterinario e/o zootecnico
EP2782592B1 (en) 2011-11-25 2017-03-15 Novozymes A/S Polypeptides having lysozyme activity and polynucleotides encoding same
AU2013211651C1 (en) 2012-01-23 2017-10-12 Morphosys Ag Use of lysozyme as a tag
RU2504386C1 (ru) * 2012-12-18 2014-01-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Препарат для профилактики диарей у новорожденных телят
DK3316703T3 (da) 2015-07-02 2022-02-21 Dsm Ip Assets Bv Fremgangsmåde til forbedring af dyrs ydeevne
US11685911B2 (en) 2016-02-16 2023-06-27 Monaghan Mushroom S Group Fungal polypeptides having lysozyme activity
EP3565582B1 (en) 2017-01-04 2022-03-09 Novozymes A/S Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
WO2018206001A1 (en) 2017-05-12 2018-11-15 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
MX2020000018A (es) * 2017-07-10 2020-10-01 Contrafect Corp Potencializacion de componentes sanguineos de actividad anti-bacteriana de proteina litica y metodos y usos de estos.
US20200215169A1 (en) * 2017-07-17 2020-07-09 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Antibacterial methods and related kits
US20200196633A1 (en) 2017-09-01 2020-06-25 Novozymes A/S Animal Feed Additives Comprising Polypeptide Having Protease Activity and Uses Thereof
WO2019043191A1 (en) 2017-09-01 2019-03-07 Novozymes A/S ANIMAL FOOD ADDITIVES COMPRISING A POLYPEPTIDE HAVING PROTEASE ACTIVITY AND USES THEREOF
US20210037856A1 (en) 2018-03-05 2021-02-11 Novozymes A/S Ruminant Feed Composition Comprising A Muramidase
JP7387095B2 (ja) 2018-03-16 2023-11-28 味の素株式会社 飼料用添加剤及び飼料
EP3843552A1 (en) 2018-08-31 2021-07-07 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
BR112021004501A2 (pt) 2018-09-11 2021-06-08 Dsm Ip Assets B.V. composição de ração animal e uso da mesma
KR20210057773A (ko) 2018-09-11 2021-05-21 디에스엠 아이피 어셋츠 비.브이. 동물 사료 조성물 및 이의 용도
EP3849338A2 (en) 2018-09-11 2021-07-21 DSM IP Assets B.V. Animal feed composition comprising muramidase and use thereof
BR112021004408A2 (pt) 2018-09-11 2021-11-03 Dsm Ip Assets Bv Composição de ração animal e uso da mesma
MX2021002787A (es) 2018-09-11 2021-05-31 Dsm Ip Assets Bv Composiciones de alimento animal y usos de las mismas.
US20220031815A1 (en) 2018-09-17 2022-02-03 Dsm Ip Assets B.V. Animal feed composition and use thereof
BR112021017999A2 (pt) 2019-03-11 2022-01-25 Novozymes As Métodos para aperfeiçoar a razão de conversão alimentar de uma ração animal, para gerar um prebiótico in situ em uma ração animal à base de milho, para diminuir a fração de milho insolúvel em uma ração animal à base de milho, para aperfeiçoar a saúde intestinal de um animal monogástrico, para causar um efeito butirogênico em um animal monogástrico, para a produção in situ de prebióticos em animais monogástricos, ração animal enriquecida com enzima, e, uso de glucuronoxilano hidrolase gh30 para preparar uma ração animal enriquecida com enzima
CN110692850A (zh) * 2019-10-09 2020-01-17 北京首朗生物科技有限公司 一种乙醇梭菌蛋白在禽类饲料中的应用
CN116867498A (zh) * 2021-02-16 2023-10-10 帝斯曼知识产权资产管理有限公司 用于通过选择性饲料添加剂干预减少致病性大肠杆菌的方法
CN116981365A (zh) 2021-03-16 2023-10-31 帝斯曼知识产权资产管理有限公司 动物饲料组合物及其用途
CN115105490B (zh) * 2022-06-16 2024-01-30 青岛农业大学 一种抑制产气荚膜梭菌的植物精油组合物及应用
WO2024121324A1 (en) 2022-12-08 2024-06-13 Novozymes A/S Polypeptide having lysozyme activity and polynucleotides encoding same

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073884A (en) * 1976-09-27 1978-02-14 W. R. Grace & Co. Promotion of feed efficiency
JPH0647550B2 (ja) * 1985-12-18 1994-06-22 日本化薬株式会社 抗ウイルス剤
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US5597564A (en) * 1986-08-28 1997-01-28 Enzacor Properties Limited Method of administering a microgranular preparation to the intestinal region of animals
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US5314962A (en) * 1987-04-07 1994-05-24 Mitsubishi Petrochemical Company Limited ABA type block copolymers
US5314692A (en) * 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
DE3841152A1 (de) * 1988-12-07 1990-06-13 Hoechst Ag Verwendung von bakterienlysierendem enzymprodukt als zusatzstoff zur verbesserung der futterverwertung in der tierproduktion
US5458876A (en) * 1988-12-21 1995-10-17 Haarman & Reimer Corp. Control of microbial growth with lantibiotic/lysozyme formulations
US5573797A (en) * 1989-02-21 1996-11-12 Viskase Corporation Film and method for surface treatment of foodstuffs with antimicrobial compositions
US5573800A (en) * 1989-02-21 1996-11-12 Viskase Corporation Antimicrobial composition for surface treatment of foodstuffs
US5573801A (en) * 1989-02-21 1996-11-12 Viskase Corporation Surface treatment of foodstuffs with antimicrobial compositions
DK0389795T3 (da) * 1989-02-25 1993-08-02 Morinaga Milk Industry Co Ltd Bioaktive midler
EP0416892B2 (en) * 1989-09-05 1998-10-21 Ajinomoto Co., Inc. Agents for the prevention and treatment of diarrhoea
US5041236A (en) * 1989-10-27 1991-08-20 The Procter & Gamble Company Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
NZ236795A (en) * 1990-03-13 1992-05-26 Microlife Technics Bacteriocin from lactococcus with molecular weight about 6000 and devices and foods containing it
US5015487A (en) * 1990-04-23 1991-05-14 Haarmann & Reimer Corp. Use of lanthionines for control of post-processing contamination in processed meat
US5043176A (en) * 1990-06-13 1991-08-27 Haarmann & Reimer Corp. Synergistic antimicrobial compositions
EP0466244A1 (en) * 1990-07-13 1992-01-15 Unilever N.V. Compositions having antibacterial properties and use of such compositions in suppressing growth of microorganisms, eg. Listeria bacteria
US5902579A (en) * 1991-08-05 1999-05-11 Bio-Technical Resources Natamycin-containing streptomyces biomass and its use in animal feed
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
JPH06145066A (ja) * 1992-02-15 1994-05-24 Imuno Japan:Kk 化学療法剤の作用増強並びに感染症予防及び治療用の医薬組 成物
ATE226635T1 (de) * 1992-05-20 2002-11-15 Secr Defence Clostridium perfringens impfstoffe
FI102807B1 (fi) * 1994-08-25 1999-02-26 Valio Oy Lactobacillus rhamnosuksen käyttö elintarviketeollisuudessa klostridien estoon
IES70514B2 (en) * 1995-04-12 1996-12-11 Teagasc Agric Food Dev Authori Bacteriocins
CN1216446A (zh) * 1996-04-23 1999-05-12 诺沃挪第克公司 动物饲料添加剂
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
AU4251897A (en) * 1996-09-05 1998-03-26 Governors Of The University Of Alberta, The Novel bacteriocins, transport and vector system and method of use thereof
US5932469A (en) * 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
FR2765078B1 (fr) * 1997-06-27 1999-09-17 Guyomarc H Nutrition Animale Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additifs alimentaires et aliments pour animaux la contenant
SE511025C2 (sv) * 1997-10-03 1999-07-26 Probi Ab Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
CZ287989B6 (cs) * 1998-03-20 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid prasat
US6033705A (en) * 1998-07-08 2000-03-07 Isaacs; Charles E. Method for treating foodstuffs to reduce or prevent microbial activity
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
CA2356088A1 (en) * 1998-12-15 2000-06-22 Rhodia Inc. Broad-range antibacterial composition
JP2000270858A (ja) * 1999-03-26 2000-10-03 Taiyo Kagaku Co Ltd リゾチーム糖複合体
US20020001582A1 (en) * 1999-04-21 2002-01-03 Charter Edward A. Methods and compositions for inhibiting microbial growth
US6451365B1 (en) * 2000-07-14 2002-09-17 Rhodia Inc. Antibacterial composition for control of gram positive bacteria in food applications
US6280725B1 (en) * 2000-01-18 2001-08-28 Lipton, Division Of Conopco, Inc. Compositions and methods for inhibiting the growth of fungi
US6287617B1 (en) * 2000-02-02 2001-09-11 Rhodia Inc. Gram negative antibacterial composition
GB2379166A (en) * 2002-10-22 2003-03-05 Dsm Nv Animal feed

Also Published As

Publication number Publication date
EP1539224A1 (en) 2005-06-15
JP4664678B2 (ja) 2011-04-06
CA2404356A1 (en) 2004-03-18
EP1902724A3 (en) 2008-07-02
BRPI0314118B1 (pt) 2016-05-10
WO2004026334A1 (en) 2004-04-01
US20110014178A1 (en) 2011-01-20
AU2003266058A1 (en) 2004-04-08
ES2298614T3 (es) 2008-05-16
DE60317799T2 (de) 2008-11-20
DE60317799D1 (de) 2008-01-10
US20050266050A1 (en) 2005-12-01
EP1539224B1 (en) 2007-11-28
CA2498143C (en) 2012-11-06
CA2498143A1 (en) 2004-04-01
EP1902724A2 (en) 2008-03-26
JP2005539070A (ja) 2005-12-22
DK1539224T3 (da) 2008-03-31

Similar Documents

Publication Publication Date Title
BR0314118A (pt) Composição antimicrobiana e método para uso
RU2219920C2 (ru) Новые аналоги жирных кислот для лечения ожирения, гипертензии и жировой инфильтрации печени
BRPI0413079A (pt) composição veterinária mastigável dútil saborosa
RU2000131222A (ru) Новые аналоги жирных кислот для лечения ожирения, гипертензии и жировой инфильтрации печени
KR20070110355A (ko) 사료 조성물 및 동물의 사육 방법
PT1178736E (pt) Composicao que contem carvacrol e timol para utilizacao como bactericida
BG107626A (bg) Приложение на бензофенантридиналкалоиди като добавка за фураж и като лечебно средство против чревновъзпаление
Huang et al. Dosage effect of zinc glycine chelate on zinc metabolism and gene expression of zinc transporter in intestinal segments on rat
BR9812894A (pt) Aditivo para água potável para pássaros e método de administrar o mesmo
Teresa Capucchio et al. The disturbed habitat and its effects on the animal population
Hoseini et al. Effects of dietary glycine administration on biochemical responses to ammonia toxicity in common carp, Cyprinus carpio
DE3920561A1 (de) Verfahren zur vermeidung von verdauungsstoerungen bei pflanzenfressenden tieren
DE60220899T2 (de) Mittel gegen stressinduzierte krankheiten
CA2704578A1 (en) Agent for improving carcass performance in finishing hogs
Agboola et al. Effects of sodium acetate and sodium propionate supplemented diets on growth performance and gut histomorphology of broiler starters
Mínguez et al. Effect of a prebiotic supplementation of mannan oligosaccharide on growth traits and mortality of rainbow trout (Oncorhynchus mykiss)
Waldenstedt et al. Mussel meal as a high quality protein source for broiler chickens.
AU700749B2 (en) Methods and compositions for sedating, anaesthetising and euthanising aquatic organisms
Hudman et al. Carcass characteristics of swine as influenced by levels of protein fed on pasture and in dry lot
KR100417471B1 (ko) 가축 사료 조성물
Hübner et al. MIX-ENABLE–Mixing young cattle and broilers
Jegede et al. Fatal abomasal sand impaction in a giraffe calf (Giraffa camelopardalis) at the University of Ilorin zoological garden
Sarma et al. Effect of dietary protein levels and slaughter stage on carcass characteristics of male Murrah buffalo calves
UDEDIBIE et al. Poultry offal meal as a protein supplement for laying hens and finisher broilers
US3422182A (en) Method of treating an animal having demodectic mange

Legal Events

Date Code Title Description
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: 674738 B.C. LTD., DBA INOVATECH BIOPRODUCTS (CA)

Free format text: A FIM DE ATENDER O SOLICITADO NA PETICAO DE ALTERACAO DE NOME NO 020060165775/RJ DE 31/10/2006, QUEIRA ESCLARECER A DIVERGENCIA ENTRE O NOME DO TITULAR DO PEDIDO E O NOME CONSTANTE NO DOCUMENTO DE ALTERACAO APRESENTADO.

B25D Requested change of name of applicant approved

Owner name: NEOVA TECHNOLOGIES INC. (CA)

Free format text: ALTERADO DE: 674738 B.C. LTD., DBA INOVATECH BIOPRODUCTS

B25G Requested change of headquarter approved

Owner name: NEOVA TECHNOLOGIES INC. (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060165775/RJ DE 31/10/2006.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/05/2016, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 38/47 (2006.01), A23K 20/105 (2016.01), A23K

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2598 DE 20-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.